Ann: September 2016 Quarterly Activity Report and Appendix 5B-CXX.AX, page-26

First 26 Last

Share
Profile

Follow
Blommer

2,935 Posts.

149

02/11/16

15:04

Post #: 20314766
Share

Originally posted by nak1811 ↑

This is my view of today's price movement pygmy:

1) Someone wanted to sell around 89,000 shares at the opening. That is not a lot, and not an insider move either;
2) There was no market depths to fill this order at higher prices (we all know that the depths disappear for CXX sometimes, and appear again when there is a correction);
3) I could not buy at higher levels to bring the price up;
4) Panic started and orders started to fill even below the opening price;
5) Guys with a lot of holdings like me that did not follow the action today might think that something wrong is happening and are tempted to sell creating these larger sell orders now;
6) These investors could also be afraid on the outcome of the elections and what would represent for CXX to raise finance or complete the offtakes;
7) Since they are very ahead with on the negotiation of these agreements, and currently choosing the best term sheet for the company, I believe the Trump risk is overestimated;

Expand

I like that you are central to what occurred today. Specifically your buy order being rejected causing unwarranted panic among the general market I bet this butterfly effect was to blame for the entire market-wide drop on the ASX today. Hopefully as people see this thread calm will be restored

CXX Price at posting: 22.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 43 more messages in this thread...

First 26 Last

Add EE1 (ASX) to my watchlist

(20min delay)
Last 1.8¢		Change 0.001(5.88%)		Mkt cap ! $9.009M

Open	High	Low	Value	Volume
1.6¢	1.8¢	1.6¢	$26.77K	1.519M

Buyers (Bids)

No.	Vol.	Price($)
1	188700	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	350000	2

View Market Depth

No.	Vol.	Price($)
2	497955	0.017
2	524864	0.016
4	814025	0.015
2	223400	0.012
1	91816	0.011

Price($)	Vol.	No.
0.018	450000	1
0.019	350000	2
0.020	1012754	3
0.021	1571232	4
0.022	400000	2

Last trade - 13.31pm 07/10/2024 (20 minute delay)

EE1 (ASX) Chart

Ann: September 2016 Quarterly Activity Report and Appendix 5B-CXX.AX, page-26

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: September 2016 Quarterly Activity Report and Appendix 5B-CXX.AX, page-26

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News